The Onco'Zine Brief

In this episode of the Onco’Zine Brief Peter Hofland reports from the 2019 annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019. Hofland talks with: - Dr. Hartmut Juhl, the Chief Executive Officer of Indivumed, a physician-led, integrated global oncology company. The company offers specialized products and services designed to support the di...

In this episode of The Onco’Zine Brief, recorded during the annual meeting of the American Society of Clinical Oncology, ASCO, being held May 31 – June 4, 2019, Peter Hofland talks with Lee Schwartzberg MD, FACP, is a Medical Oncologist and Hematologist at West Cancer Center, Germantown, TN, and Dr. Shannon Westin, MD, MPH., FACOG, Associate Professor, Department of Gynecologic Oncology and Reprod...

In this episode of The Onco’Zine Brief Peter Hofland report from the annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019. The American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. During the annual meeting Peter Hofland spoke with: • An...

This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Eugene Luskin, Chief Executive Officer of Redmond, Washington-based Vyrty. As part of a growing push to let patients control and manage their own medical history, Luskin’s Vyrty has launche...

This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Adil Akhtar, MD, an Oncologist and Palliative Care Expert, Associate Professor, Department of Medical Oncology & Hematology at the Oakland University-William Beaumont School of Medicine. He...

In this edition of The Onco’Zine Brief Peter Hofland talks with Mr. Isaac Israel, the CEO of Kitov Pharma, a pharmaceutical drug development company developing new options to treat osteoarthritis pain and hypertension simultaneously, as well as novel anticancer drugs. The company is developing an investigational drug called NT-219, a novel small molecule drug designed to targets two signal protein...

In this edition of The Onco’Zine Brief Peter Hofland talk with Dr. Lisa Stearns, the founder and medical director of Center for Pain and Supportive Care, in Phoenix, Arizona. An internationally recognized Interventional Pain Specialist, board certified in hospice and palliative medicine and pain management, Dr. Stearns’ passion for changing the face of acute and chronic pain-treatment is evidenced...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Salman Hyder, Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center at the University of Missouri, in Columbia, Missouri. Together with a team of researchers Dr. Hyder found that a combination drug therapy, reduces the spread of trip...

In this edition of The Onco’Zine Brief Peter Hofland talks with Greg Van Wyk, Chief Executive Officer and Chief Medical Officer of Noxopharm, a clinical-stage Australian drug development company with offices in Sydney, New York and Hong Kong. The company is developing a number of drug candidates including an advanced dosage formulation of the generic anti-cancer agent called idronoxil, which is de...

In this edition of The Onco’Zine Brief Peter Hofland talks with Charlie Covert, Vice President & General Manager Targeted Drug Delivery, Restorative Therapies Group - Pain Division at Medtronic, about opioids and pain management in patients with cancer. While considered safe, reliable, and effective for all types of pain, opioids are also a potentially abuseable drugs. And the public health conseq...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Kenneth Vega, chief of Gastroenterology and co-director of the Digestive Health Center at Augusta University Health, a public research university and academic medical center located in Augusta, Georgia (USA). Hofland and Vega talk about the prevention of colorectal cancer by means of a colonoscopy. Unfortunately, many people postp...

In this edition of The Onco’Zine Brief Peter Hofland talks with Padma Sundar. Ms. Sundar is Vice President of Strategy and Market Access at CellMax Life, a company developing a simple blood test or liquid biopsy for cancer screening. The company is using a proprietary technology for detecting pre-cancer and cancer cells in a single blood sample. Together with a team of experts across multiple disc...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most aggressive cancer that begins within the brain. Dr. Sanai is the director of the Ivy Brain Tumor Center at the Barrow Neurological Institute in Phoenix, Ariz...

In this edition of The Onco’Zine Brief Peter Hofland talks with Robert Goff about Medical Debt. Goff is one of the co-authors of a new book (“End Medical Debt: Curing America’s $1 Trillion Unpayable Healthcare Debt”) about the subject. He co-authored the book with Jerry Ashton and Craig Antico. In today's show Hofland and Goff talk about the problem of medical debt and how we got here. They talk a...

This week in The Onco’Zine Brief Peter Hofland, Ph. D talks with Guy Chamberland, M.Sc., Ph. D, about medicinal cannabis. Chamberland, is a Master Herbalist as well as Chief Executive Officer and Chief Scientific Officer of Tetra Bio-Pharma, a biopharmaceutical company developing cannabinoid-based drugs. Tetra Bio-Pharma has a clinical development program aimed at bringing novel drugs and treatmen...

In the third and final part of a 3-part series about colorectal cancer, developed in collaboration with the online journal OncoZine at www.oncozine.com , Peter Hofland, PhD. talks with Paul J. Berggreen, MD and Daniel M. Jondle, MD, both from Arizona Digestive Health, in Phoenix, Arizona, and Sukhdeep S Padda, MD from Arizona Gastrointestinal Associates and Arrowhead Gastroenterology Associates, i...

In the second part of a 3-part series about colorectal cancer, developed in collaboration with the online journal OncoZine at www.oncozine.com , Peter Hofland, PhD. talks with Paul J. Berggreen, MD and Daniel M. Jondle, MD, both from Arizona Digestive Health, in Phoenix, Arizona, and Sukhdeep S Padda, MD from Arizona Gastrointestinal Associates and Arrowhead Gastroenterology Associates, in Glendal...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Paul Berggreen and Dr. Daniel Jondle, both from Arizona Digestive Health, in Phoenix, Arizona, about Colorectal Cancer. Today’s program is the first of a 3-part series about the disease, which is the third most common cancer diagnosed in the United States. Colorectal Cancer is the second leading cause of death from cancers that af...

In this edition of The Onco’Zine Brief Peter Hofland talks with Charlie Johnson, Chief Executive Officer of ADC Bio, a biotechnology company, specialized in the development of Antibody-drug Conjugates. Antibody-drug Conjugates, also known as ADCs, are a novel type of targeted anticancer agents. Today 4 drugs in this class of drugs have been approved by regulators around the world, but there are mo...

In this Edition of the OncoZine Brief, recorded during the Annual meeting of American Society of Clinical Oncology (ASCO), which took place June 1-5, 2018 in Chicago Illinois, Peter Hofland and Sonia Portillo interview Dr. Sotirios Stergiopoulos, who is the Chief Medical Officer of Ipsen, a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops...

In this edition of The Onco’Zine Brief, recorded during the Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, June 1 - 5, 2018, Peter Hofland and Sonia Portillo talk with Michael Pehl, President and Chief Executive Officer of Immunomedics, a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC). At this year’s ASCO meeting, nea...

This week in The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with experts in oncology about some of the results presented during the annual meeting for the American Society of Clinical Oncology, held in Chicago, Ill, June 1 - 5, 2018. The theme of this year’s ASCO conference is: Delivering Discoveries: Expanding the Reach of Precision Medicine. More than 40,000 people attended the meetin...

In this Edition of the Onco'Zine Brief, Peter Hofland and Sonia Portillo talk with Dr. John B. Kisiel, Assistant Professor of Medicine and a Consultant in the, Division of Gastroenterology and Hepatology, Department of Internal Medicine at the Mayo Clinic in Rochester, Minnesota. The overall goal of Dr. Kisiel is to improve the clinical outcomes of patients with gastrointestinal illness by providi...

In this edition of The Onco’Zine Brief, Sonia Portillo talks with Neil Canavan about the people involved in developing novel, advanced – and sometimes – highly personalized - anti-cancer treatments. Canavan is a veteran journalist with more than 20 years of experience reporting on science and medicine. For the last 5 years he has reported exclusively on issues related to drug development in cancer...

In the edition of The Onco’Zine Brief Peter Hofland and Sonia Portillo review some of the most exciting and important study to be presented at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO), to be held in Chicago, June 1 - 5, 2018. The theme of this year’s conference is: Delivering Discoveries: Expanding the Reach of Precision Medicine. More than 2,500 abstracts we...